Unda 23 Liquid
NDC Package 62106-1122-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Unda 23 (equisetum arvense, hypericum perforatum, nux vomica, quercus robur, tormentilla,) liquids is uses For the temporary relief of symptoms associated with occasional incontinence minor urinary discomfort Directions Adults and adolescents (12 years and older) Take 5 drops three times daily or as recommended by your healthcare practitioner.Children (under 12 years)Take under the direction of your healthcare practitioner. This formulation utilizes a liquid delivery system. Marketed by Seroyal Usa, this product is identified by NDC 62106-1122.

Identification & Billing

NDC Package Code
62106-1122-8
Package Description
1 BOTTLE, GLASS in 1 CARTON / 20 mL in 1 BOTTLE, GLASS
Product Code
62106-1122
11-Digit Billing Format
62106112208

Clinical Specifications

Proprietary Name
Unda 23
Non-Proprietary Name
Equisetum Arvense, Hypericum Perforatum, Nux Vomica, Quercus Robur, Tormentilla,
Substance Name
Equisetum Arvense Branch; Hypericum Perforatum; Potentilla Erecta Root; Quercus Robur Twig Bark; Strychnos Nux-vomica Seed
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses For the temporary relief of symptoms associated with occasional incontinence minor urinary discomfort Directions Adults and adolescents (12 years and older) Take 5 drops three times daily or as recommended by your healthcare practitioner.Children (under 12 years)Take under the direction of your healthcare practitioner.

Regulatory & Marketing

Labeler Name
Seroyal Usa
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
12-14-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62106-1122-8 identifies a specific commercial package of 1 bottle, glass in 1 carton / 20 ml in 1 bottle, glass of Unda 23, a human over the counter drug labeled by Seroyal Usa. This liquid is formulated for oral use and contains equisetum arvense branch; hypericum perforatum; potentilla erecta root; quercus robur twig bark; strychnos nux-vomica seed as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Seroyal Usa on December 14, 2015. The current certification is valid through December 31, 2026.

How is this Seroyal Usa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62106112208. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
62106-1122-8
11-Digit CMS (5-4-2)
62106-1122-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.